A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle

Ashley M. Vaughan, Sebastian A. Mikolajczak, Nelly Camargo, Viswanathan Lakshmanan, Mark Kennedy, Scott Eugene Lindner, Jessica L. Miller, Jen C C Hume, Stefan H I Kappe

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Plasmodium falciparum is the pathogenic agent of the most lethal of human malarias. Transgenic P. falciparum parasites expressing luciferase have been created to study drug interventions of both asexual and sexual blood stages but luciferase-expressing mosquito stage and liver stage parasites have not been created which has prevented the easy quantification of mosquito stage development (e.g. for transmission blocking interventions) and liver stage development (for interventions that prevent infection). To overcome this obstacle, we have created a transgenic P. falciparum NF54 parasite that expresses a GFP-luciferase transgene throughout the life cycle. Luciferase expression is robust and measurable at all life cycle stages, including midgut oocyst, salivary gland sporozoites and liver stages, where in vivo development is easily measurable using humanized mouse infections in conjunction with an in vivo imaging system. This parasite reporter strain will accelerate testing of interventions against pre-erythrocytic life cycle stages.

Original languageEnglish (US)
Pages (from-to)143-147
Number of pages5
JournalMolecular and biochemical parasitology
Volume186
Issue number2
DOIs
StatePublished - Dec 1 2012

Fingerprint

Plasmodium falciparum
Life Cycle Stages
Luciferases
Parasites
Culicidae
Liver
Sporozoites
Oocysts
Infection
Salivary Glands
Transgenes
Malaria
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Parasitology

Cite this

Vaughan, Ashley M. ; Mikolajczak, Sebastian A. ; Camargo, Nelly ; Lakshmanan, Viswanathan ; Kennedy, Mark ; Lindner, Scott Eugene ; Miller, Jessica L. ; Hume, Jen C C ; Kappe, Stefan H I. / A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. In: Molecular and biochemical parasitology. 2012 ; Vol. 186, No. 2. pp. 143-147.
@article{225e18fae3144e53aa449b22954ceb66,
title = "A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle",
abstract = "Plasmodium falciparum is the pathogenic agent of the most lethal of human malarias. Transgenic P. falciparum parasites expressing luciferase have been created to study drug interventions of both asexual and sexual blood stages but luciferase-expressing mosquito stage and liver stage parasites have not been created which has prevented the easy quantification of mosquito stage development (e.g. for transmission blocking interventions) and liver stage development (for interventions that prevent infection). To overcome this obstacle, we have created a transgenic P. falciparum NF54 parasite that expresses a GFP-luciferase transgene throughout the life cycle. Luciferase expression is robust and measurable at all life cycle stages, including midgut oocyst, salivary gland sporozoites and liver stages, where in vivo development is easily measurable using humanized mouse infections in conjunction with an in vivo imaging system. This parasite reporter strain will accelerate testing of interventions against pre-erythrocytic life cycle stages.",
author = "Vaughan, {Ashley M.} and Mikolajczak, {Sebastian A.} and Nelly Camargo and Viswanathan Lakshmanan and Mark Kennedy and Lindner, {Scott Eugene} and Miller, {Jessica L.} and Hume, {Jen C C} and Kappe, {Stefan H I}",
year = "2012",
month = "12",
day = "1",
doi = "10.1016/j.molbiopara.2012.10.004",
language = "English (US)",
volume = "186",
pages = "143--147",
journal = "Molecular and Biochemical Parasitology",
issn = "0166-6851",
publisher = "Elsevier",
number = "2",

}

Vaughan, AM, Mikolajczak, SA, Camargo, N, Lakshmanan, V, Kennedy, M, Lindner, SE, Miller, JL, Hume, JCC & Kappe, SHI 2012, 'A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle', Molecular and biochemical parasitology, vol. 186, no. 2, pp. 143-147. https://doi.org/10.1016/j.molbiopara.2012.10.004

A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. / Vaughan, Ashley M.; Mikolajczak, Sebastian A.; Camargo, Nelly; Lakshmanan, Viswanathan; Kennedy, Mark; Lindner, Scott Eugene; Miller, Jessica L.; Hume, Jen C C; Kappe, Stefan H I.

In: Molecular and biochemical parasitology, Vol. 186, No. 2, 01.12.2012, p. 143-147.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle

AU - Vaughan, Ashley M.

AU - Mikolajczak, Sebastian A.

AU - Camargo, Nelly

AU - Lakshmanan, Viswanathan

AU - Kennedy, Mark

AU - Lindner, Scott Eugene

AU - Miller, Jessica L.

AU - Hume, Jen C C

AU - Kappe, Stefan H I

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Plasmodium falciparum is the pathogenic agent of the most lethal of human malarias. Transgenic P. falciparum parasites expressing luciferase have been created to study drug interventions of both asexual and sexual blood stages but luciferase-expressing mosquito stage and liver stage parasites have not been created which has prevented the easy quantification of mosquito stage development (e.g. for transmission blocking interventions) and liver stage development (for interventions that prevent infection). To overcome this obstacle, we have created a transgenic P. falciparum NF54 parasite that expresses a GFP-luciferase transgene throughout the life cycle. Luciferase expression is robust and measurable at all life cycle stages, including midgut oocyst, salivary gland sporozoites and liver stages, where in vivo development is easily measurable using humanized mouse infections in conjunction with an in vivo imaging system. This parasite reporter strain will accelerate testing of interventions against pre-erythrocytic life cycle stages.

AB - Plasmodium falciparum is the pathogenic agent of the most lethal of human malarias. Transgenic P. falciparum parasites expressing luciferase have been created to study drug interventions of both asexual and sexual blood stages but luciferase-expressing mosquito stage and liver stage parasites have not been created which has prevented the easy quantification of mosquito stage development (e.g. for transmission blocking interventions) and liver stage development (for interventions that prevent infection). To overcome this obstacle, we have created a transgenic P. falciparum NF54 parasite that expresses a GFP-luciferase transgene throughout the life cycle. Luciferase expression is robust and measurable at all life cycle stages, including midgut oocyst, salivary gland sporozoites and liver stages, where in vivo development is easily measurable using humanized mouse infections in conjunction with an in vivo imaging system. This parasite reporter strain will accelerate testing of interventions against pre-erythrocytic life cycle stages.

UR - http://www.scopus.com/inward/record.url?scp=84870405599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870405599&partnerID=8YFLogxK

U2 - 10.1016/j.molbiopara.2012.10.004

DO - 10.1016/j.molbiopara.2012.10.004

M3 - Article

VL - 186

SP - 143

EP - 147

JO - Molecular and Biochemical Parasitology

JF - Molecular and Biochemical Parasitology

SN - 0166-6851

IS - 2

ER -